Alterity Therapeutics Limited
ATHE · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $77,477 | $45,661 | $28,409 | $15,246 |
| - Cash | $33,159 | $4,537 | $12,639 | $12,320 |
| + Debt | $155 | $106 | $159 | $256 |
| Enterprise Value | $44,474 | $41,230 | $15,929 | $3,181 |
| Revenue | $3,833 | $1,606 | $2,119 | $1,901 |
| % Growth | 138.7% | -24.2% | 11.5% | – |
| Gross Profit | $3,769 | $1,542 | $2,045 | $1,827 |
| % Margin | 98.3% | 96% | 96.5% | 96.1% |
| EBITDA | -$7,107 | -$7,526 | -$14,615 | -$8,334 |
| % Margin | -185.4% | -468.6% | -689.9% | -438.5% |
| Net Income | -$4,974 | -$7,173 | -$12,616 | -$6,507 |
| % Margin | -129.8% | -446.7% | -595.5% | -342.4% |
| EPS Diluted | -0.42 | -0.84 | -1.2 | -1.56 |
| % Growth | 50% | 30% | 23.1% | – |
| Operating Cash Flow | -$2,355 | -$8,360 | -$8,111 | -$4,495 |
| Capital Expenditures | $0 | $0 | $0 | -$2 |
| Free Cash Flow | -$2,355 | -$8,360 | -$8,111 | -$4,864 |